Loading
Latest filing published 24 Nov 2020 for Vaxil Bio Ltd. (formerly Emerge Resources Corp.), €16k.
No signal scores available.
Gadi Levin appears in our data through filings on Vaxil Bio Ltd. (formerly Emerge Resources Corp.) shares, published by SEDI. In total, 3 filings cover trades dated from 1 March 2016 to 23 November 2020.
No open-market sale appears; the market trades are 1 purchase worth €16k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 1 share grant. So far in 2020, the count stands at 1 purchase and no sales.
Most recently, on 24 November 2020, the filings show an open-market purchase worth €16k in Vaxil Bio Ltd. (formerly Emerge Resources Corp.). Typically, a trade is published a median of 18 days after it takes place. That lag is the time during which only the insider knows about the trade. Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations